Victor W. van Beusechem
Chief Tech/Sci/R&D Officer at ORCA Therapeutics BV
Profile
Victor W.
van Beusechem is currently the Chief Scientific Officer at ORCA Therapeutics BV.
Previously, he worked as a Senior Scientist at Introgene BV and Janssen Vaccines & Prevention BV.
He holds a doctorate degree from the University of Leiden and an undergraduate degree from Vrije Universiteit Amsterdam.
Victor W. van Beusechem active positions
| Companies | Position | Start |
|---|---|---|
ORCA Therapeutics BV
 ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Chief Tech/Sci/R&D Officer | - |
Former positions of Victor W. van Beusechem
| Companies | Position | End |
|---|---|---|
Janssen Vaccines & Prevention BV
 Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Chief Tech/Sci/R&D Officer | 1997-12-31 |
| Introgene BV | Chief Tech/Sci/R&D Officer | 1997-12-31 |
Training of Victor W. van Beusechem
| University of Leiden | Doctorate Degree |
| Vrije Universiteit Amsterdam | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
| Introgene BV | Health Technology |
- Stock Market
- Insiders
- Victor W. van Beusechem
